- Home
- NOAH vs CRMD Comparison
NOAH vs CRMD Comparison
Compare NOAH & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOAH
- CRMD
- Stock Information
- Founded
- NOAH 2005
- CRMD 2006
- Country
- NOAH China
- CRMD United States
- Employees
- NOAH N/A
- CRMD N/A
- Industry
- NOAH Investment Managers
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- NOAH Finance
- CRMD Health Care
- Exchange
- NOAH Nasdaq
- CRMD Nasdaq
- Market Cap
- NOAH 780.8M
- CRMD 925.6M
- IPO Year
- NOAH 2010
- CRMD 2010
- Fundamental
- Price
- NOAH $11.53
- CRMD $11.59
- Analyst Decision
- NOAH Buy
- CRMD Strong Buy
- Analyst Count
- NOAH 2
- CRMD 8
- Target Price
- NOAH $12.25
- CRMD $17.57
- AVG Volume (30 Days)
- NOAH 346.7K
- CRMD 4.6M
- Earning Date
- NOAH 08-27-2025
- CRMD 10-29-2025
- Dividend Yield
- NOAH 5.02%
- CRMD N/A
- EPS Growth
- NOAH N/A
- CRMD N/A
- EPS
- NOAH 0.75
- CRMD 0.79
- Revenue
- NOAH $360,100,505.00
- CRMD $121,484,498.00
- Revenue This Year
- NOAH N/A
- CRMD $404.81
- Revenue Next Year
- NOAH $6.32
- CRMD $56.11
- P/E Ratio
- NOAH $15.46
- CRMD $14.64
- Revenue Growth
- NOAH N/A
- CRMD 14970.29
- 52 Week Low
- NOAH $7.67
- CRMD $5.60
- 52 Week High
- NOAH $14.90
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- NOAH 40.98
- CRMD 37.78
- Support Level
- NOAH $11.77
- CRMD $12.73
- Resistance Level
- NOAH $12.84
- CRMD $13.83
- Average True Range (ATR)
- NOAH 0.48
- CRMD 0.81
- MACD
- NOAH -0.07
- CRMD -0.23
- Stochastic Oscillator
- NOAH 0.76
- CRMD 2.60
About NOAH Noah Holdings Limited
Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.